Stocks-DXCM-DexCom Inc

DXCM DexCom Inc

70.35 -0.13 (-0.18%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

DexCom Inc price

-1.98% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
27.48B
Day’s Range
69.77
-
70.93
52W Range
62.30
-
141.53
Volume (3M)
4.67M
Price-Earnings Ratio
42.17
Revenue
3.95B

Set price alert

Price alerts notify you when an asset hits a target you set.

DexCom Inc Latest News

View All

About DexCom Inc

Located in San Diego, California, DexCom Inc. is a medical device company that manufactures and distributes continuous glucose monitoring systems for diabetes management. DexCom was founded in 1999 by John F. Burd and has released several versions of its devices with improved communications, sensors, and calibrations. DexCom owns over 40 patents and has its headquarters in San Diego, California. It operates in the US as well as internationally. The company's products include DexCom G6, a glucose monitoring system that can be integrated with other medical devices, and DexCom Share, a remote monitoring system that uses a mobile app to transmit glucose information to the cloud, where it can then be sent to up to five recipients. DexCom owns several key subsidiaries: TypeZero Technologies LLC, Nintamed GmbH & Co. KG, DXCM Sweden AB, and SweetSpot Diabetes Care, Inc. In 2008, Dexcom signed several partnerships to promote development. These included those with Insulet Corporation, Animas Corporation, and Edwards Lifesciences. In 2015, DexCom entered into an agreement with Tandem Diabetes Care, Inc. The company trades on the NASDAQ using the ticker DXCM. The firm acquired Australasian Medical & Scientific Ltd (AMSL) and New Zealand Medical & Scientific Ltd (NZMS) in August 2021, with the goal of providing goods and services in the allergy, diabetes, medical, point of care/diagnostics, regenerative medicine, and scientific segments. Monitor DXCM stock using your eToro watchlist and receive real-time news and price updates.
Show More
CEO
Kevin Ronald Sayer, CPA
Employees
9.6K
Founded
1999
HQ
San Diego, California, US

Did you know? DexCom's first-ever continuous glucose monitoring device received FDA approval in 2006.
Top Discussions

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
59
High
Industry 
Avg. 50 
53
Environment
66
Social
52
Governance

Analyst Forecast

Consensus
Strong Buy
Price Target
95.55

People Also Bought